ADAMTSL5 and CDH11: putative epigenetic markers for therapeutic resistance in acute lymphoblastic leukemia

Overview of attention for article published in Hematology, March 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

patent: 3 patents

f1000: 1 research highlight platform

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 21 Mendeley

Summary Patents Research highlights Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

Methods and kits for diagnosing and treating cancer based on overexpression of ADAMTSL5…

Application CN-112020649-A

China

METHOD AND KIT FOR DIAGNOSING AND FOR TREATMENT OF A CANCER BASED ON THE OVEREXPRESSION…

Application WO-2019185919-A1

World Intellectual Property Organisation (WIPO)

DIAGNOSIS AND TREATMENT OF A CANCER BASED ON THE OVEREXPRESSION OF THE ADAMTSL5 GENE

Application EP-3546944-A1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.